The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Valeant Pharmaceuticals International Inc

TSX: VRX
Delayed quote

$301.21

Today's change-7.24 -2.35%
Updated September 3 1:57 PM EDT. Delayed by at least 15 minutes.
 

Valeant Pharmaceuticals International Inc

TSX: VRX
Delayed quote

$301.21

Today's change-7.24 -2.35%
Updated September 3 1:57 PM EDT. Delayed by at least 15 minutes.

Valeant Pharmaceuticals International Inc down $7.24

Valeant Pharmaceuticals International Inc is sharply lower today, dropping $7.24 or 2.35% to $301.21. Shares have lost 2.98% over the last five days, but have gained 81.09% over the last year to date. This security has outperformed the S&P TSX by 145.76% during the last year.

Key company metrics

  • Trailing P/E93.36×
  • P/E 1 year forward28.31×
  • Forward PEG0.85×
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS$3.23
Updated September 3 1:57 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.29%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue2,7322,1912,2802,056
Total other revenue--------
Total revenue2,7322,1912,2802,056
Gross profit2,0471,6161,6901,495
Total cost of revenue685575590561
Total operating expense2,3911,6681,6721,372
Selling / general / administrative686574525504
Research & development81565959
Depreciation / amortization58536586393
Interest expense (income), net operating--------
Unusual expense (income)1779240687
Other operating expenses, total17767-232
Operating income342523608684
Interest income (expense), net non-operating-413-298-225-258
Gain (loss) on sale of assets--------
Other--------
Income before tax-65155590377
Income after tax-5275534276
Income tax, total-138156100
Net income-5374535275
Total adjustments to net income--------
Net income before extra. items-5374535275
Minority interest-1-11-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-5374535275
Inc. avail. to common incl. extra. items-5374535275
Diluted net income-5374535275
Dilution adjustment--00--
Diluted weighted average shares344343342341
Diluted EPS excluding extraordinary itemsvalue per share-0.150.211.560.81
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.190.342.821.01